Small Cap Feast
Small Cap Feast – 13 December 2018
Dish of the Day:
No Joiners Today.
No Joiners Today.
Off the Menu:
No Leavers Today
No Leavers Today
What’s Cooking in the IPO Kitchen?
Main Market (Specialist Funds)
The Global Sustainability Trust -aiming for attractive risk-adjusted returns by investing primarily in private market investments that are expected to have a positive environmental and social impact raising c.£200m. Due end Nov.
PetroTal Corp is an oil and gas company whose shares are currently admitted to trading on the TSXV. The Company is focused on development of oil and gas assets in Peru and it currently has controlling interests in three onshore Peru license blocks. No new funds being raised. Due 21 Dec. Mkt cap c.£80m
Litigation Capital Management—provider of litigation financing and ancillary services, moving from ASX (ASX:LCA) to AIM. Offer TBC. Due 18 Dec. Mkt Cap A$64m.
Crossword Cybersecurity PLC* (NEX:CCS)—the technology commercialisation company focusing exclusively on the cyber security sector is due to start trading on AIM 14 December. Raising £2m at 290p. Mkt cap at issue price £13.6m.
Manolete Partners—leading UK insolvency litigation financing business looking to join AIM raising £16.3m as a placing and £13.1 realised by the selling shareholder at 175p. Market cap £76.3m, expected 14 December
Greenfields Petroleum (TSX-V:GNF) production focused company with operated assets in Azerbaijan seeking AIM dual listing including $60m private placement. Mkt cap $12.6m CAD. Expected mid December.
Integumen* (SKIN.L) 0.51p £2.32m
Integumen has announced a cross-platform biophysics agreement with AI developer, Rinocloud Limited, in association with Cork Institute of Technology’s Nimbus embedded systems research institute and its Cappa Photonics Laboratory to develop Labskin-On-A-Chip (“LOAC”) technology.
Pioneering animal free, clinical research skin-treatment test platform by exploiting Photonics. Labskin is grown on a microchip where light is generated, detected and manipulated, using the cutting-edge use of lasers and fibre-optics on an electro-optical device.
Labskin-on-a-Chip as a pre-clinical and post-clinical platform is a major step up for all skin related disease treatments. The completion of the project over the next 12 months is expected to provide every dermatology clinic with a desktop ability to take a swab of the patient’s own bacteria, place it on the Labskin and provide the best course of treatment.
Thor Mining (THR.L) 1.6p £10.04m
The Board of Thor Mining, announced an upgraded and increased mineral resource estimate containing tungsten, copper and now zinc, for the Desert Scheelite deposit at Pilot Mountain in Nevada USA.
The Desert Scheelite mineral resource estimate now comprises 10.7 million tonnes at 0.26% WO₃, 19.38 gram/tonne Silver (Ag), 0.15% copper (Cu), & 0.38% zinc (Zn) (above cut-off grade of 0.15% WO3);
The upgraded mineral resource estimate represents a 6.5% increase in the scheelite inventory for Desert Scheelite, now containing 27,700 tonnes of WO₃ (tungsten trioxide) 85% of which is in the Indicated category;
For the first time, the estimate includes zinc in the resource inventory, contributing an additional potential by-product stream to the project;
The planned flotation recovery process, currently being trialled, is likely to recover zinc sulphides into concentrate with minimal additional cost;
The resource inventory still has considerable growth potential via the Gun Metal and Good Hope deposits, as well as further potential upside at both Desert Scheelite and Garnet.
Springfield Props (SPR.L) 106p £102m
The housebuilder in Scotland offering private and affordable housing, has won Best New Share Plan at this year’s ProShare Awards, which recognise and reward innovation and excellence within the share plan industry.
The Best New Share Plan award recognises newly-launched employee share plans that are designed to link clearly with business objectives. It must also be effectively communicated and have a simple process to encourage employee participation, resulting in strong levels of uptake. In particular, the judges were impressed with Springfield’s above-average take-up, especially that this level of engagement was achieved in a working environment where the majority of the workforce is deployed outdoors over multiple sites and that it included a very high take-up amongst both younger and female employees.
Accesso Tech (ACSO.L) 1,250p £330.72m
The premier technology solutions provider to leisure, entertainment, cultural and hospitality markets, has announced an expansion of its partnership with Merlin Entertainments to implement a combination of accesso’s ticketing, queuing and guest experience solutions at The Bear Grylls Adventure in Birmingham, England.
The Bear Grylls Adventure will combine accesso Passport®, accesso LoQueueSM, The Experience EngineTM and accesso PrismSM, here renamed BearTag, to deliver an unparalleled user experience to its guests. Upon arrival and check-in, each guest will receive a BearTag loaded with their custom itinerary, which will guide them through their chosen adventures with live messages and reservation notifications throughout their visit. The technology will also enable guests to make secure, cashless payments for meals and merchandise, receive marketing offers in real-time and claim free photos from their unforgettable experience.
OnTheMarket (OTMP.L) 106p £65.36m
As of 12 Dec, it has listing agreements with UK estate and letting agents with more than 12,000 branches. This increase of more than 6,500 branches since Admission to AIM in Feb has been achieved in just over ten months.
The figures include 60 offices, largely made up of smaller firms, which have recently entered full tariff paying listing agreements. These firms will receive new shares in OnTheMarket plc alongside the listing commitments they have made. The shares are subject to 5-year lock-in arrangements to ensure that new shareholders’ interests are closely aligned with those of all other agent investors.
Growth to date has been almost exclusively from offering free listings under short-term introductory trial offers, with a view to converting these to full tariff contracts when the value of its offering has been demonstrated.
The sales team is continuing to see encouragingly high levels of agent support and conversion to signed contracts when it presents the opportunity of listing on an agent-backed portal.
Nanoco Group (NANO.L) 39.6p £106.37m
AGM Statement from the specialist in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials. “Since we updated the market in mid-October with our preliminary results, we have continued to make good progress in delivering the various scopes of work for our US Customer for materials used in the electronics industry. Our Runcorn facility expansion remains on track to be completed by the end of the current calendar year and we continue to deliver excellent performance in enhancing the quality and performance of our next generation materials. The Runcorn plant will enter its next development phase in Jan 2019 when it will undergo commissioning and stress testing prior to commercial volume manufacture early in the first half of the next financial year.”
“We continue to work with a range of customers and partners on a number of near term potentially transformative technological and commercial activities.” “We remain confident in delivering the Board’s expectations for our full year results.”
Tungsten Corp (TUNG.L) 32p £40.35m
HY Oct 18 results from the provider of the secure business transaction network that brings businesses and their suppliers closer together with unique technology that revolutionises invoice processing, maximises efficiency and improves cash flow.
Revenue increased 3% in H1-FY19 to £17.6m (H1-FY18: £17.1m); up 3% at constant exchange rates
£4.2m improvement in EBITDA to £0.75m loss (H1-FY18: £5m loss)
Gross margin of 93.2%, a 220 basis point improvement from 91% in H1-FY18
FY19 revenue expectation now £36m to £36.5m, representing full year constant currency growth of 7% to 10%. This reflects H2-FY19 revenue growth over H1-FY19 of 5% to 8% (10% to 16% annualised), both at constant rates of exchange. EBITDA profit for the full financial year, as a result of reduced adjusted operating expenses.
Draper Esprit (GROW.L) 510p £505.19m
The venture capital firm investing in and developing high growth digital technology businesses, today announces it is leading a $40m investment in FINALCAD, the leading building, infrastructure and construction mobile software platform.
Draper Esprit invested £12.4m (€14m) in the round, alongside international investors Cathay Innovation and Salesforce Ventures. The latest Series C funding round brings the total funds raised by FINALCAD to $60m. The investment will be used to extend the product platform into the energy, operations and maintenance sectors, increase headcount globally, and to invest further in R&D.
Other recent investments led by Draper Esprit include $14m Form3 Series B round, $31m Series A Fluidic Analytics round and a £14.5m ($19m) growth round for Crowdcube, in addition to the previously announced Secondary portfolio acquisition of DFJ Europe X fund for £25.9m ($33.7m).
Hummingbird Resources (HUM.L) 18.75p £64.21m
Second set of drill results from the 2018 exploration campaign in Mali, the focus of which is to convert Resources to Reserves and, in time, to extend the life of mine from the Company’s Yanfolila Gold Mine. Further positive results from those announced in September and shows the high-grade potential at Gonka owing to the significant numbers of wide and high-grade drill intercepts encountered to date.
Best Intersections Include
- 15m @ 16.03g/t from 207m depth (GKRCD0013)
- 0.05m @ 4.63g/t from 118m depth (GKDD0020)
- 11m @ 4.11g/t from 79m depth (GKRCD0044)
Komana West (‘KW’) Deposit
- 15m @ 4.25 g/t from 8m depth (KWDD0609)
Komana West South Extension
- 12m @ 1.90 g/t from 90m depth (KWRC0419)
VR Education (VRE.L) 11p £19.8m
The virtual reality (‘VR’) technology company focused on the education space, is pleased to announce the full commercial release of ENGAGE, its online virtual learning and corporate training platform. At the time of its IPO in March 2018, the Group raised £6m gross to, amongst other activities, fund the further development of its proprietary VR education platform, “ENGAGE” .
ENGAGE version 1.0 is now available on all industry leading VR devices including HTC Vive, Oculus Rift and Windows Mixed Reality devices. Development of ENGAGE mobile is now complete and will be made available early next year on devices such as the Oculus Go, Vive Focus and selected Google DayDream devices. The content that the Group has already created following its partnerships with the BBC, the University of Bristol, the University of Oxford and the University of New Haven will immediately be available on the platform.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email firstname.lastname@example.org with “unsubscribe me”.